A Phase 1 Study to Evaluate Multiple-Doses of Upadacitinib on the Cytochrome P450 Substrates

Study Identifier
M19-139
CT.gov Identifier
Not available
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Not available
Sign up for trial alerts

Study Details

Medical Condition
  • Healthy Volunteer
    • Study Drug
    N/A
    Phase
    Phase 1
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria

    Protocol Summary

    To evaluate the effect of repeated doses of upadacitinib extended release regimen on the pharmacokinetics of sensitive probe substrates of CYP enzymes in healthy adult subjects

    Study Locations

    No locations found.